MLTX
Price
$13.87
Change
+$0.13 (+0.95%)
Updated
Dec 24 closing price
Capitalization
982.65M
63 days until earnings call
Intraday BUY SELL Signals
PRLD
Price
$2.23
Change
+$0.04 (+1.83%)
Updated
Dec 24 closing price
Capitalization
140.19M
83 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLTX vs PRLD

Header iconMLTX vs PRLD Comparison
Open Charts MLTX vs PRLDBanner chart's image
MoonLake Immunotherapeutics
Price$13.87
Change+$0.13 (+0.95%)
Volume$536.46K
Capitalization982.65M
Prelude Therapeutics
Price$2.23
Change+$0.04 (+1.83%)
Volume$107.88K
Capitalization140.19M
MLTX vs PRLD Comparison Chart in %
MLTX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLTX vs. PRLD commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Buy and PRLD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (MLTX: $13.87 vs. PRLD: $2.23)
Brand notoriety: MLTX and PRLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 26% vs. PRLD: 6%
Market capitalization -- MLTX: $982.65M vs. PRLD: $140.19M
MLTX [@Biotechnology] is valued at $982.65M. PRLD’s [@Biotechnology] market capitalization is $140.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whilePRLD’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • PRLD’s FA Score: 1 green, 4 red.
According to our system of comparison, PRLD is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while PRLD’s TA Score has 6 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 4 bearish.
  • PRLD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PRLD is a better buy in the short-term than MLTX.

Price Growth

MLTX (@Biotechnology) experienced а -0.57% price change this week, while PRLD (@Biotechnology) price change was +14.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

MLTX is expected to report earnings on Feb 26, 2026.

PRLD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($983M) has a higher market cap than PRLD($140M). PRLD YTD gains are higher at: 74.902 vs. MLTX (-74.386). PRLD has higher annual earnings (EBITDA): -119.27M vs. MLTX (-227.94M). MLTX has more cash in the bank: 380M vs. PRLD (55M). PRLD has less debt than MLTX: PRLD (17.9M) vs MLTX (75.7M). PRLD has higher revenues than MLTX: PRLD (10.5M) vs MLTX (0).
MLTXPRLDMLTX / PRLD
Capitalization983M140M702%
EBITDA-227.94M-119.27M191%
Gain YTD-74.38674.902-99%
P/E RatioN/AN/A-
Revenue010.5M-
Total Cash380M55M691%
Total Debt75.7M17.9M423%
TECHNICAL ANALYSIS
Technical Analysis
MLTXPRLD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 8 days ago
73%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signal:
Gain/Loss:
PRLD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEUCX39.710.18
+0.46%
Principal Equity Income C
IBNCX25.260.07
+0.28%
Nomura Balanced Fund Class C
BSGRX15.940.02
+0.13%
BlackRock Advantage Small Cap Gr R
DHSIX25.74N/A
N/A
Diamond Hill Small Cap I
LSHEX28.10-0.05
-0.18%
Kinetics Spin-Off and Corp Rest No Load

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.95%
KALA - MLTX
85%
Closely correlated
+12.32%
IOBT - MLTX
75%
Closely correlated
+5.50%
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
-0.13%
NUVL - MLTX
48%
Loosely correlated
+0.89%
More

PRLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRLD has been loosely correlated with NAUT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PRLD jumps, then NAUT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRLD
1D Price
Change %
PRLD100%
+1.83%
NAUT - PRLD
48%
Loosely correlated
+2.56%
MLTX - PRLD
35%
Loosely correlated
+0.95%
AMRN - PRLD
35%
Loosely correlated
+0.29%
AXON - PRLD
35%
Loosely correlated
+0.02%
IMNM - PRLD
34%
Loosely correlated
+2.76%
More